2023 Form 5500 filing — Regeneron Pharmaceuticals, Inc. 401(K) Savings Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240920081306NAL0004273571001) for Regeneron Pharmaceuticals, Inc. 401(K) Savings Plan, reported by Regeneron Pharmaceuticals, Inc. under EIN 13-3444607 and plan number 001. It reports 11,675 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240920081306NAL0004273571001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Regeneron Pharmaceuticals, Inc.
- EIN
- 13-3444607
- Plan number
- 001
- Location
- Tarrytown, NY
- Participants
- 11,675
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $2,247,714,975
- Total liabilities (EOY)
- $12
- Net assets (EOY)
- $2,247,714,963
- Employer contributions
- $73,353,990
- Participant contributions
- $177,378,414
- Total income / additions
- $641,292,607
- Benefits paid
- $80,504,235
- Administrative expenses
- $548,754
- Total expenses
- $81,118,671
- Net increase / (decrease)
- $560,173,936
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Fidelity Investments Institutional | RECORDKEEPER | $445,419 | $0 |
| Capfinancial Partners, LLC | INVESTMENT ADVISOR | $92,060 | not reported in the loaded dataset |
| Crowe Llp | ACCOUNTANT\AUDITOR | $14,088 | not reported in the loaded dataset |